Delivery Order HHSD200201250430I-HHSD2002012504300005
Award Date 9/29/17
Potential Completion Date 9/28/22
Potential Value $4.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Nashville, TN 37232, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,072,649.00, was issued by the Centers for Disease Control and Prevention (CDC) to The Vanderbilt University, a leading private research institution. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery vehicle, which supports the CDC's efforts to conduct research and analysis related to vaccine safety. The award does not have a set-aside designation, reflecting Vanderbilt's status as a large...
- This is a prime contract award from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC), a leading academic medical center and nonprofit healthcare provider. The $33,581,705.97 fixed-price contract, awarded under the CDC's Fiscal Year 2021 Broad Agency Announcement, supports VUMC's research on topics related to Topic 9.1. The contract has no set-aside designation. VUMC is a major recipient of federal funding and has extensive experience managing...
- This is a $129,000 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Vanderbilt University's Sponsored Programs Administration division. The contract is for "other functions" and does not have a set-aside designation. Vanderbilt University is a leading private research university known for its expertise across various disciplines, including medical research and healthcare analysis. The university has an extensive history of receiving...
- <p>The Centers for Disease Control and Prevention (CDC) awarded a $2.1 million delivery order against the Clinical Immunization Safety Assessment (CISA) master indefinite-delivery/indefinite-quantity contract to The Vanderbilt University. The Vanderbilt University will serve as the lead contractor to provide CLINICAL VACCINE SAFETY EVALUATION services for the CDC in Nashville, Tennessee under a cost-no-fee contract that runs from September 29, 2022 through September 28, 2023.</p>
- This is a firm fixed-price federal contract award to Vanderbilt University Medical Center (VUMC), a non-profit healthcare provider in Nashville, Tennessee. The contract was awarded by the Centers for Disease Control and Prevention (CDC) on December 18, 2020 for $3,749,778.73 to support COVID-19 host pathogen discovery research under the CDC's Broad Agency Announcement (BAA) program. The contract has a period of performance through November 29, 2022. VUMC, which has a long history of federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $4.8 million definitive contract to Vanderbilt University Medical Center to conduct research titled "Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Disease in Adults." The prime contractor will lead a network of 16 academic medical centers as subcontractors to study the effectiveness of influenza vaccines in preventing critical illness. This award was...
- Vanderbilt University Medical Center was awarded a definitive cost-plus-fixed-fee contract valued at $14,222,774.34 by the Centers for Disease Control and Prevention under funding opportunity announcement topic 9.3. The prime contractor will lead a network of subcontractors to conduct a prospective cohort study to assess the effectiveness of COVID-19 and influenza vaccines in preventing virus transmission within households. Major subcontractors include the Universities of Arizona, Emory,...
- This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds...
- This is a $13,460,835.60 delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Vanderbilt University Medical Center. The contract is for an Adult Inpatient and Outpatient VE Case Control Study, which will evaluate the effectiveness of COVID-19 and influenza vaccines. This order falls under the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery/indefinite quantity...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,995,944 definitive cost-no-fee contract to Vanderbilt University Medical Center for Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2. Vanderbilt University Medical Center will serve as the prime contractor and has subcontracted portions of the work to 26 other institutions, including The Cleveland Clinic Foundation, University of Utah, Beth Israel Deaconess...